Characteristics of Patients with Early Rheumatoid Arthritis Who Have a Delayed Response to Treatment with Methotrexate in Monotherapy or in Combination with Adalimumab

被引：0
|
作者：
Smolen, Josef S. [1 ]
Bu, Xianwei [2 ]
Wang, Xin [2 ]
Suboticki, Jessica L. [3 ]
Kavanaugh, Arthur [4 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria
[2] AbbVie Inc, N Chicago, IL USA
[3] AbbVie Inc, Mettawa, IL USA
[4] Univ Calif San Diego, Med, La Jolla, CA 92093 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1419
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    Breedveld, FC
    Weisman, MH
    Kavanaugh, AF
    Cohen, SB
    Pavelka, K
    van Vollenhoven, R
    Sharp, J
    Perez, JL
    Spencer-Green, GT
    ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 26 - 37
  • [42] Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis
    Çalgüneri, M
    Pay, S
    Çaliskaner, Z
    Apras, S
    Kiraz, S
    Ertenli, I
    Çobankara, V
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : 699 - 704
  • [43] The Relationship Between Efficacy and Toxicity in Patients with Rheumatoid Arthritis Receiving Methotrexate in Combination with Adalimumab
    Burmester, Gerd
    Kaeley, Gurjit S.
    Kavanaugh, Arthur
    Gabay, Cem
    MacCarter, Daryl
    Nash, Peter
    Takeuchi, Tsutomu
    Cardoso, Anabela
    Liu, Shufang
    Kupper, Hartmut
    Kalabic, Jasmina
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [44] Reduction of Concomitant Oral Methotrexate or Corticosteroids in Combination Treatment with Adalimumab Does Not Affect Effectiveness in Patients with Rheumatoid Arthritis
    Keystone, Edward
    Breedveld, Ferdinand
    Kavanaugh, Arthur
    Zhang, Ying
    Sainsbury, Iain
    Kalabic, Jasmina
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] REDUCTION OF CONCOMITANT ORAL METHOTREXATE OR CORTICOSTEROIDS IN COMBINATION TREATMENT WITH ADALIMUMAB DOES NOT AFFECT EFFECTIVENESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Keystone, E.
    Breedveld, F.
    Kavanaugh, A.
    Zhang, Y.
    Sainsbury, I.
    Kalabic, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1008 - 1008
  • [46] Efficacy Of Adalimumab Plus Methotrexate Therapy In Rheumatoid Arthritis Non-Responders Receiving Methotrexate Monotherapy Or Adalimumab Combination Therapy: Results From The Optima Trial
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S999 - S1000
  • [47] EFFICACY OF ADALIMUMAB PLUS METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS NON-RESPONDERS RECEIVING METHOTREXATE MONOTHERAPY OR ADALIMUMAB COMBINATION THERAPY: RESULTS FROM THE OPTIMA TRIAL
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2014, 53 : 89 - 89
  • [48] Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis
    Tang, Boxiong
    Rahman, Mirza
    Waters, Heidi C.
    Callegari, Peter
    CLINICAL THERAPEUTICS, 2008, 30 (07) : 1375 - 1384
  • [49] Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis
    Lee, S-S.
    Park, Y-W.
    Park, J. J.
    Kang, Y. M.
    Nam, E. J.
    Kim, S. I.
    Lee, J. H.
    Yoo, W-H.
    Lee, S-I.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (01) : 11 - 14
  • [50] Methotrexate Combination Therapies for early rheumatoid Arthritis
    Lorenz, Judith
    AKTUELLE RHEUMATOLOGIE, 2024, 49 (04) : 218 - 218
12345